6 výsledky
FIELD OF THE INVENTION
This invention relates to the medical use of sulphated polysaccharides for the treatment of a symptomatic bone marrow edema that may be present within the musculoskeletal system of a mammal.
BACKGROUND OF THE INVENTION
Bone marrow edema (BME) is a common multifactorial
FIELD OF THE INVENTION
This invention relates to the medical use of sulphated polysaccharides for the treatment of a symptomatic bone marrow edema that may be present within the musculoskeletal system of a mammal.
BACKGROUND OF THE INVENTION
Bone marrow edema (BME) is a common multifactorial
FIELD OF THE INVENTION
This invention relates to the medical use of sulphated polysaccharides for the treatment of a symptomatic bone marrow edema that may be present within the musculoskeletal system of a mammal.
BACKGROUND OF THE INVENTION
Bone marrow edema (BME) is a common multifactorial
BACKGROUND OF THE INVENTION
Sinonasal complaints affect at least 15% of the population in the United States of America with predictable patient morbidity and financial impact. Importantly, any modality that can alleviate sinonasal complaints warrants serious attention. Among various treatments
PHARMACEUTICAL COMPOSITION FOR MENIERE'S DISEASE
This application is a U.S. national stage of International Application No. PCT/JP2007/050172 filed Jan. 10, 2007.
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition for treating Meniere's disease, in particular a
BACKGROUND OF THE INVENTION
In certain diseases, particularly in kidney diseases, water retention within an animal body presents serious difficulties. With total failure of the renal system, water build-up in the body, called edema, can lead to an accumulation in the blood of constituents normally